Evaluation of HIV-1 kinetic models using quantitative discrimination analysis
暂无分享,去创建一个
[1] Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1990, Disease markers.
[2] S Bonhoeffer,et al. A stochastic model for primary HIV infection: optimal timing of therapy. , 1999, AIDS.
[3] A S Perelson,et al. Modeling HIV infection of CD4+ T-cell subpopulations. , 1994, Journal of theoretical biology.
[4] Sonya J Snedecor,et al. Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment. , 2003, Journal of theoretical biology.
[5] M. Re,et al. Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay , 1994, Journal of clinical microbiology.
[6] M A Nowak,et al. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.
[7] Andrew N. Phillips,et al. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.
[8] R. Gallo,et al. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Zack,et al. CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] George E. P. Box,et al. Model Discrimination and Criticism with Single-Response Data , 1996 .
[11] S. J. Flint,et al. Principles of Virology: Molecular Biology, Pathogenesis, and Control , 1999 .
[12] G L Drusano,et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. , 1992, The New England journal of medicine.
[13] A. Perelson. Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.
[14] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[15] B. Gazzard,et al. Where does HIV live? , 2004, The New England journal of medicine.
[16] Z. Grossman,et al. Mathematical models of HIV pathogenesis , 1997, Nature Medicine.
[17] M. Baseler,et al. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. , 1990, Annals of internal medicine.
[18] W. E. Stewart,et al. Discrimination and goodness of fit of multiresponse mechanistic models , 1998 .
[19] P. Kahn. Susceptibility Genes: Pointing a Way to Prevention? , 1996, Science.
[20] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] R J D B,et al. Target Cell Limited and Immune Control Models of HIV Infection : A Comparison , 1998 .
[22] A S Perelson,et al. Effect of Drug Efficacy and the Eclipse Phase of the Viral Life Cycle on Estimates of HIV Viral Dynamic Parameters , 2001, Journal of acquired immune deficiency syndromes.
[23] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[24] B. Walker,et al. A rapid method for quantitating the frequency of peripheral blood cells containing HIV-1 DNA. , 1991, Journal of acquired immune deficiency syndromes.
[25] H C Tuckwell,et al. A stochastic model for early HIV-1 population dynamics. , 1998, Journal of theoretical biology.
[26] S. Bloor,et al. Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV‐1‐infected individuals , 1993, AIDS.
[27] Steve Kaye,et al. Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug Resistance , 2001, Journal of acquired immune deficiency syndromes.
[28] S E Macatonia,et al. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. , 1990, Immunology.
[29] Warren E. Stewart,et al. Parameter estimation from multiresponse data , 1992 .
[30] C H Fox,et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.
[31] K. Nusbaum. Book Review: Principles of Virology: Molecular Biology, Pathogenesis, and Control of Animal Viruses , 2004 .
[32] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[33] J. Yin,et al. Quantitative intracellular kinetics of HIV type 1. , 1999, AIDS research and human retroviruses.
[34] M A Nowak,et al. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] Huldrych F. Günthard,et al. Quantification of In Vivo Replicative Capacity of HIV‐1 in Different Compartments of Infected Cells , 2001, Journal of acquired immune deficiency syndromes.
[36] Martin A Nowak,et al. Mathematical models of HIV pathogenesis and treatment. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[37] W. Tan,et al. Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies. , 1998, Mathematical biosciences.
[38] Anthony S Fauci,et al. HIV and AIDS: 20 years of science , 2003, Nature Medicine.
[39] M A Nowak,et al. Human immunodeficiency virus drug therapy and virus load , 1997, Journal of virology.
[40] Warren E. Stewart,et al. Bayesian Estimation of Common Parameters From Multiresponse Data With Missing Observations , 1981 .
[41] R. Pomerantz,et al. High percentages of CD4‐positive lymphocytes harbor the HIV‐1 provirus in the blood of certain infected individuals , 1993, AIDS.
[42] J. Albert,et al. Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection , 1991, Journal of virology.
[43] R. Pomerantz,et al. Twenty years of therapy for HIV-1 infection , 2003, Nature Medicine.
[44] Sebastian Bonhoeffer,et al. Glancing behind virus load variation in HIV-1 infection. , 2003, Trends in microbiology.
[45] O. Bagasra,et al. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. , 1992, The New England journal of medicine.
[46] S. Spector,et al. Human immunodeficiency virus DNA is present in a high percentage of CD4+ lymphocytes of seropositive individuals. , 1991, The Journal of infectious diseases.
[47] A S Perelson,et al. Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. , 1998, Journal of theoretical biology.
[48] P. Simmonds,et al. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers , 1990, Journal of virology.
[49] P. Hartigan,et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. , 1996, The New England journal of medicine.
[50] Mario Roederer,et al. T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis , 2004, Journal of Virology.
[51] M. Stevenson. HIV-1 pathogenesis , 2003, Nature Medicine.